Seth Woodruff
Overview
Explore the profile of Seth Woodruff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Video Interventions for Reducing Health Inequity in Cancer Screening Programmes: a Systematic Review
Richardson-Parry A, Silva M, Valderas J, Donde S, Woodruff S, van Vugt J
J Racial Ethn Health Disparities
. 2023 Aug;
11(5):2898-2924.
PMID: 37603223
Background: Health equity can lead to disparities in cancer screening, treatment, and mortality. This systematic review aims to identify and describe interventions that used video or DVD formats to reduce...
2.
Richardson-Parry A, Silva M, Valderas J, Donde S, Woodruff S, van Vugt J
Eur J Cancer Prev
. 2023 May;
32(4):396-409.
PMID: 37144585
Background And Objectives: Significant health inequities exist in screening uptake for certain types of cancer. The review question was to identify and describe interactive, tailored digital, computer, and web-based interventions...
3.
Richardson-Parry A, Baas C, Donde S, Ferraiolo B, Karmo M, Maravic Z, et al.
Int J Equity Health
. 2023 Jan;
22(1):19.
PMID: 36707816
Background: Health inequities lead to low rates of cancer screening in certain populations, such as low-income and ethnic minority groups. Different interventions to address this have been developed with mixed...
4.
Woodruff S, Lee A, Carrier M, Feugere G, Abreu P, Heissler J
J Thromb Thrombolysis
. 2019 Mar;
47(4):495-504.
PMID: 30859370
In patients with active cancer and acute venous thromboembolism (VTE), the low-molecular-weight-heparin (LMWH) dalteparin is more effective than vitamin K antagonist (VKA) in reducing the risk of recurrent venous thromboembolism...
5.
Dranitsaris G, Shane L, Woodruff S
J Oncol Pharm Pract
. 2017 Sep;
25(1):68-75.
PMID: 28857713
Background: Patients with cancer have an elevated risk of venous thromboembolism. Importantly, patients with cancer, who have metastatic disease, renal insufficiency, or are receiving anticancer therapy, have an even higher...
6.
Dranitsaris G, Shane L, Galanaud J, Stemer G, Debourdeau P, Woodruff S
Support Care Cancer
. 2017 Feb;
25(7):2093-2102.
PMID: 28204995
Background: International guidelines recommend extended duration secondary prophylaxis in cancer patients who develop primary venous thromboembolism (VTE). Agent selection is guided in part by one large randomized trial (i.e., CLOT;...
7.
Dranitsaris G, Shane L, Crowther M, Feugere G, Woodruff S
Clinicoecon Outcomes Res
. 2017 Feb;
9:65-73.
PMID: 28138260
Background: Patients with cancer are at increased risk of venous thromboembolism (VTE) and the risk is further elevated after a primary VTE. To reduce the risk of recurrent events, extended...
8.
Dranitsaris G, Shane L, Burgers L, Woodruff S
Clin Appl Thromb Hemost
. 2016 Jul;
22(7):617-26.
PMID: 27436663
Background: In a randomized trial (ie, Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer [CLOT]) that evaluated secondary prophylaxis...
9.
Woodruff S, Feugere G, Abreu P, Heissler J, Ruiz M, Jen F
J Thromb Thrombolysis
. 2016 Jun;
42(4):494-504.
PMID: 27344439
Venous thromboembolism (VTE) is a common and serious complication in patients with cancer; treatment guidelines recommend extended therapy of ≥6 months with low-molecular-weight heparin (LMWH) for treatment and prevention of...
10.
Schmidt-Rohlfing B, Silny J, Woodruff S, Gavenis K
Rheumatol Int
. 2008 Apr;
28(10):971-7.
PMID: 18389240
Although several effects of electromagnetic fields (EMFs) on articular cartilage have been reported in recent studies, the use of EMFs to treat osteoarthritis remains a matter of debate. In an...